Expertise

Expertise

  

Joshua Funder

Independent Consultant

  • Biotech and Life Sciences
Dr. Joshua Vincent Funder, also known as Josh, Ph.D., M.D., was a Partner at GBS Venture Partners Limited till January 2015. Dr. Funder had been with GBS Venture Partners Limited since 2004. Dr. Funder worked in corporate strategy and development at Infinity Pharmaceuticals in Boston. He also worked as a Consultant at the Boston Consulting Group, focusing primarily on corporate strategy in the high-tech and bio-pharmaceutical sectors. In addition, Dr. Funder worked with the Clinton Foundation HIV/AIDS initiative to successfully negotiate reduced prices for anti-retrovirals and initiate pharmaceutical supplies across Eastern and Southern Africa. He served as an Interim Chief Executive Officer at Proacta Inc. Dr. Funder has been a Director of Euthymics Bioscience, Inc. since 2010. He was a Director of Peplin Inc. Dr. Funder serves as a Non-Employee Director at Neurovance, Inc., Spinifex Pharmaceuticals Inc., Biocomm Pty Ltd, OPAL Inc, Pathway Therapeutics Ltd., and Nuon Therapeutics. He chairs Per Capita and is on the board of the John Button Foundation. He served as a Non-Employee Director at Celladon Corporation since January 2012 until June 4, 2015. He served as Director of Spinifex Pharmaceuticals Pty Ltd. He holds a D.Phil in Intellectual Property for Biotechnology from Oxford University, where Dr. Funder studied as a Rhodes Scholar. He holds a Master of Laws degree at the London School of Economics , B.Sc. with honors and Bachelor of Laws with honors degrees from Melbourne University